Megestrol Acetate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 14 USDMF, 8 CEP/COS, 3 KDMF, 6 NDC API, 10 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

64 FDF Dossiers, 21 FDA Orange Book, 25 Europe, 2 Canada, 16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 125MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 4 SPI Pharma, 7 DKSH, 1 Pharm-RX Chemical, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 Kirsch Pharma, 1 ACG Worldwide, 10 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 18 BASF, 2 CD Formulation, 11 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 23 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 13 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders, 40 Coating Systems & Additives, 37 Thickeners and Stabilizers, 26 Direct Compression, 24 Solubilizers, 23 Granulation, 22 Controlled & Modified Release, 20 Topical, 18 Disintegrants & Superdisintegrants, 17 Parenteral, 13 Lubricants & Glidants, 12 Rheology Modifiers, 11 Co-Processed Excipients, 11 Taste Masking, 11 Emulsifying Agents, 10 Film Formers & Plasticizers, 9 API Stability Enhancers, 7 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 2 Coloring Agents

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 18 Regulatory FDF Prices

MARKET PLACE

5 APIs, 4 FDF Dossiers

REF. STANDARDS & IMPURITIES

6 EDQM, 3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20264 / DOSAGE - SUSPENSION;ORAL - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
MEGESTROL ACETATE(UNII: TJ2M0FR8ES) (MEGESTROL - UNII:EA6LD1M70M)	MEGESTROL ACETATE	40mg in 1

Inactive Ingredients

Ingredient Name	E.R. Squibb & Sons, L.L.C.
ALCOHOL(3K9958V90M)
CITRIC ACID MONOHYDRATE(2968PHW8QP)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
POLYSORBATE 80(6OZP39ZG8H)
SODIUM BENZOATE(OJ245FE5EU)
SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR)
SUCROSE(C151H8M554)
WATER(059QF0KO0R)
XANTHAN GUM(TTV12P4NEE)

Setid 65b28775 Ee59 88cf E4d8 372c6c79ad14 Applno 20264 Form Suspension Oral Dosage 40mg Ml - Drug Product Composition: Megestrol Acetate